Clinical Trials Directory

Trials / Unknown

UnknownNCT05241626

AS-OCT of the Cornea in Thyroid Diseases

Anterior Segment Optical Coherence Tomography Study of the Tear Film and Cornea in Thyroid Eye Diseases.

Status
Unknown
Phase
Study type
Observational
Enrollment
70 (estimated)
Sponsor
Minia University · Academic / Other
Sex
All
Age
Healthy volunteers

Summary

use the anterior segment optical coherence tomography (AS-OCT) to evaluate the tear meniscus parameters, total corneal thickness (CT), and epithelial thickness in active and inactive thyroid eye diseases (TED) patients and compare them with age-matched controls.

Detailed description

A prospective case-control clinical study. The study subjects were divided into 3 groups, group 1 of inactive thyroid patients, group 2 of active thyroid patients, and group 3 of healthy controls. The AS-OCT was used to measure lower tear meniscus parameters (tear meniscus height (TMH), tear meniscus depth (TMD), and tear meniscus area (TMA)), total CT and epithelial thickness

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTAS-OCTOptical Coherence Tomography (OCT) creates detailed cross-sectional images of the anterior and posterior segments using low coherence interferometry. OCT is a noninvasive, real-time method for evaluating the tear meniscus, total corneal thickness (CT), and corneal epithelial thickness

Timeline

Start date
2021-05-11
Primary completion
2022-10-29
Completion
2022-10-29
First posted
2022-02-16
Last updated
2022-02-16

Locations

2 sites across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05241626. Inclusion in this directory is not an endorsement.